Balchem Corporation (BCPC)
NEUTRALFundamental
71
मूल्य
$179.24
मार्केट कैप
$5.79B
भाग 1 · कंपनी का मूल्य कितना है
अवलोकन
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
बैलेंस शीट और तरलता
राजस्व
$1.09B
पिछले 12 महीने (30/6/2026 तक)
शुद्ध आय
$164M
पिछले 12 महीने (30/6/2026 तक)
Free Cash Flow
-
कुल इक्विटी
$1.26B
कुल देनदारियाँ
$429M
Current Ratio
2.66
Interest Coverage
-
Debt/EBITDA
0.65
Earnings Per Share
राजस्व और शुद्ध आय
Free Cash Flow
आय विवरण
ऐतिहासिक विवरण
समय के साथ मार्जिन
समय के साथ ऋण
ऋण कितना भारी है
वृद्धि तालिका
वृद्धि — राजस्व
Fair Value अनुमान
Fair Value
$126.59
वर्तमान मूल्य
$179.24
Margin of Safety
-41.6%
Fair Value सीमा
$82.29 - $170.90
अनुमान विधियाँ
मूल्यांकन मेट्रिक्स
P/E Ratio
34.87
ROE
12.3%
P/B Ratio
4.34
P/FCF
-
Gross Margin
36.3%
ROIC
10.9%
लाभप्रदता Radar
Value Creation (Economic Moat)
ROIC
10.9%
WACC
9.0%
ROIC − WACC
+2.0 pp
ROIC exceeds the cost of capital — the company is creating value for shareholders.
Fundamental विश्लेषण मानदंड
पास (17)
- EPS shows upward trend
- EPS CAGR 10.73%
- Price CAGR 8.01%
- ROIC 11.0%
- Gross Margin 36.3%
- Debt/Equity ratio
- Operating Margin 20.2%
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 12.8%
- Revenue Growth 5Y 8.1%
- Analyst Consensus 78% Buy
- Earnings Quality (OCF/NI) 1.34
- Share Dilution -0.3%
- Net Margin Trend 15.1% vs 14.5%
- Piotroski F-Score 9/9
फेल (6)
- P/B Ratio 4.34
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Earnings Surprise avg 0.9%
- PEG Ratio 2.72
अनुपलब्ध (5)
- P/FCF NaN
- Dividend Payout NaN%
- Positive Free Cash Flow
- CapEx intensity
- Interest Coverage
Piotroski F-Score
मजबूत वित्तीय स्वास्थ्य
Earnings गुणवत्ता
उच्च गुणवत्ता: earnings नकदी द्वारा समर्थित
शेयर Dilution
शेयर वापस खरीद रही है। शेयरधारक अनुकूल
प्रशासन
कार्यकारी टीम
| नाम | पद | आयु |
|---|---|---|
| Mr. Theodore Lee Harris | CEO, President & Chairman | 60 |
| Mr. Carl Martin Bengtsson | Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health | 48 |
| Ms. Hatsuki Miyata J.D. | Executive VP, Chief Legal Officer & Secretary | 49 |
| Mr. M. Brent Tignor | Senior VP & Chief Human Resources Officer | 47 |
| Mr. Frederic Boned | Senior VP, Head of Digital Transformation & AI and GM of Human Nutrition & Health | 46 |
| Ms. Erin L. Gilson | VP & Chief Accounting Officer | - |
| Mr. Martin Luther Reid | Senior VP & Chief Supply Chain Officer | 58 |
| Mr. Job L. van Gunsteren | Senior VP & GM of Specialty Products | 48 |
| Mr. George Graham | Senior VP and Chief R&D Officer | 55 |
Audit जोखिम
3
बोर्ड जोखिम
4
मुआवजा जोखिम
4
शेयरधारक अधिकार जोखिम
7
भाग 2 · कीमत और खरीदने का समय
यह हिस्सा यह नहीं बताता कि कंपनी अच्छी है या नहीं: यह तय करने में मदद करता है कि उसे कब खरीदें, जब फंडामेंटल आपको आश्वस्त कर चुके हों। इसमें: तकनीकी विश्लेषण, संभावना, ऐतिहासिक गिरावट, गामा एक्सपोज़र।
Latest News
Recent headlines for BCPC, sourced from Markets Gazette.